International Development Grant

Prevention and Control of Communicable Diseases

Project Number: CA-3-A030833003

Status: Closed

Country/Region:

Peru 30.00%
Ecuador 15.00%
Colombia 15.00%
Paraguay 40.00%

Maximum Contribution: $9,257,531.00

Start Date: September 23, 2005

End Date: July 31, 2011

Duration: 5.9 years

Project Description

The Prevention and Control of Priority Communicable Diseases (PCPCD) project is being implemented by the Pan American Health Organization (PAHO) in collaboration with the Ministries of Health of Colombia Ecuador Paraguay Peru and Venezuela. This project contributes to the prevention and control of communicable diseases that cause the greatest burden of morbidity and mortality among children youth and adults in South America. In children the diseases that frequently affect their health are diarrhoeal disease and acute respiratory infections. In youth and adults these diseases are sexually transmitted infections (STIs) including HIV/AIDS Chagas disease and tuberculosis. The project also strengthens the capacity of institutions responsible for planning managing and delivering sustainable and comprehensive programs for the prevention and control of the most prevalent communicable diseases. The first stage of this project with PAHO has already been completed. The total value of the two stages together is $10 million.

Progress & Results Achieved

Results achieved as of the end of the project (February 2011) include: In Colombia over 2 100 health professionals health promoters and indigenous leaders received training in a tuberculosis control strategy promoted by the World Health Organization and the Pan American Health Organization called Directly Observed Treatment Strategy (DOTS); and 1 109 health professionals and indigenous leaders were trained in a systematic approach to children’s health that focuses on preventing as well as curing illness called “Integrated Management of Childhood Illnesses ” (IMCI). In Ecuador 8 300 professionals were trained in clinical community and neonatal IMCI; the IMCI strategy was implemented in 2 000 health establishments; 4 211 health professionals health promoters professors students and community members also received education and training to help prevent Chagas disease a potentially life-threatening illness caused by a parasite and spread by insects. In Paraguay information on Chagas disease and dengue an infectious tropical disease caused by a virus was incorporated in science curriculum in schools; and over 800 health professionals were trained in prevention and care for sexually transmitted infections. The project contributed to passing a law that ensured that all pregnant women and their partners received free testing and treatment for syphilis. This law helped to improve capacity to diagnose syphilis among pregnant women by 87% and the capacity to treat syphilis by 82%. In Peru an agreement was signed by the Ministry of Health the Pan American Health Organization and mayors of 25 districts in three departments to include funding for Chagas in their municipal development plans for health promotion and disease prevention and control activities; and 911 people (681 women and 230 men) participated in training to help them integrate gender equality in health activities.

Key Information

Executing Agency:
PAHO - Pan American Health Organization

Reporting Organization:
Global Affairs Canada

Program:
NGM Americas

Last Modified:
September 19, 2025

Development Classifications

DAC Sector:

Health policy and administrative management 30%
Basic health care 20%
Infectious disease control 40%
Reproductive health care 5%
STD control including HIV/AIDS 5%

Aid Type: Contributions to specific-purpose programmes and funds managed by implementing partners

Collaboration: Bilateral

Finance Type: Aid grant excluding debt reorganisation

Selection Mechanism:
Pre-APP

Policy Markers
Level 1 Children's issues
Level 1 Youth Issues
Level 1 Indigenous Issues
Major Funding (>$1M)
Budget Breakdown
2005-04-01 to 2006-03-31 $9,257,531 CAD
Geographic Information
965
Project Number: CA-3-A030833003